U.S. Medical Device Testing Services Market to Reach USD 7.05 Billion by 2035 at a 10.16% CAGR, While Europe Benefits from ...

In a constantly growing global medical device market, marked by increasingly strict regulation and rising demands in patient ...

Medical innovation is exciting. It’s thrilling to think a new therapy, device or product can improve the quality of or save ...

Polyrizon is a development-stage biotech company that specializes in medical device hydrogels delivered as nasal sprays. The company’s proprietary Capture and Contain hydrogel technology uses ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced successful results ...

Raanana, Israel, July 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company” or "Polyrizon”), a development-stage biotech company specializing in the development of innovative ...

Polyrizon Ltd. (NASDAQ: PLRZ) shares gathered steam to begin Thursday trading. The development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced ...

A global survey of companies pursuing 'nanomedicine' indicates that nanotechnology is taking root in the drug and medical device industry. This article presents data from the above study showing that ...

OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog, and display technology, today announced the availability of several new OVMed ® ...